<p>Cresco Labs（OTCMKTS:CRLBF - 获取免费报告）于周五公布了其财报。公司报告本季度每股收益为（$0.04），低于分析师一致预期的（$0.03），差距为（$0.01），据 Zacks 报道。Cresco Labs 的净利润率为负 20.65%，股本回报率为负 16.61%。</p>
<h2>Cresco Labs 股票表现</h2>
<ul>
<li>大麻行业的十亿美元减税</li>
</ul>
<p>OTCMKTS:CRLBF 在周五的午盘交易中下跌了$0.07，达到$1.03。该股票的交易量为 1,725,173 股，而其平均交易量为 936,485 股。该公司的市值为 5.1784 亿美元，市盈率为-2.64，贝塔值为 1.59。Cresco Labs 的 12 个月低点为$0.43，12 个月高点为$2.30。该公司的 50 日简单移动平均为$0.98，200 日简单移动平均为$1.06。公司的速动比率为 1.60，流动比率为 2.59，债务与股本比率为 1.72。</p>
<h2>华尔街分析师观点</h2>
<p>另外，Zacks Research 在 3 月 31 日（星期二）的一份报告中将 Cresco Labs 的股票评级从 “强烈卖出” 上调至 “持有”。一位股票研究分析师给予该股票 “强烈买入” 评级，另一位则给予公司 “持有” 评级。根据 MarketBeat 的数据，该公司的平均评级为 “买入”。</p>
<p><strong>查看我们关于 Cresco Labs 的最新研究报告</strong></p>
<h2>Cresco Labs 公司简介</h2>
<p>（获取免费报告）</p>
<p>Cresco Labs 是一家在美国运营的垂直整合多州大麻公司。该公司从事各种大麻产品的种植、制造和分销，包括花朵、预卷烟、浓缩物、蒸汽器、食用产品和酊剂。Cresco Labs 的运营涵盖种植设施、加工实验室以及一个批发分销中心网络，向关键大麻市场的持牌药房和零售商供应产品。</p>
<p>公司的产品组合分为多个品牌平台，如 MÜV、Reserve 和 High Supply，旨在满足成人使用和医疗大麻市场的不同细分市场。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们认为比 Cresco Labs 更好的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Cresco Labs 吗？</h2>
<p>在考虑 Cresco Labs 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Cresco Labs 并不在名单上。</p>
<p>虽然 Cresco Labs 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

CRLBF

<p>Cresco Labs (OTCMKTS:CRLBF) 报告季度每股收益为（$0.04），低于预期 $0.01。该公司的股本回报率为负，达到 16.61%，净利润率为负，达到 20.65%。股票交易价格下跌至 $1.03，市值为 5.1784 亿美元。分析师的评级不一，有一项强烈买入和一项持有。Cresco Labs 运营于大麻行业，提供多种产品，覆盖多个市场</p>

<p>Cresco Labs (OTCMKTS:CRLBF - Get Free Report) announced its earnings results on Friday. The company reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.01), Zacks reports. Cresco Labs had a negative net margin of 20.65% and a negative return on equity of 16.61%.</p>
<div class="lb-trans"><p>Cresco Labs（OTCMKTS:CRLBF - 获取免费报告）于周五公布了其财报。公司报告本季度每股收益为（$0.04），低于分析师一致预期的（$0.03），差距为（$0.01），据 Zacks 报道。Cresco Labs 的净利润率为负 20.65%，股本回报率为负 16.61%。</p>
</div><h2>Cresco Labs Stock Performance</h2>
<div class="lb-trans"><h2>Cresco Labs 股票表现</h2>
</div><ul>
<li>The Cannabis Sector's Billion-Dollar Tax Cut</li>
</ul>
<div class="lb-trans"><ul>
<li>大麻行业的十亿美元减税</li>
</ul>
</div><p>OTCMKTS:CRLBF traded down $0.07 during midday trading on Friday, reaching $1.03. The stock had a trading volume of 1,725,173 shares, compared to its average volume of 936,485. The stock has a market cap of $517.84 million, a P/E ratio of -2.64 and a beta of 1.59. Cresco Labs has a 12-month low of $0.43 and a 12-month high of $2.30. The firm has a fifty day simple moving average of $0.98 and a two-hundred day simple moving average of $1.06. The company has a quick ratio of 1.60, a current ratio of 2.59 and a debt-to-equity ratio of 1.72.</p>
<div class="lb-trans"><p>OTCMKTS:CRLBF 在周五的午盘交易中下跌了$0.07，达到$1.03。该股票的交易量为 1,725,173 股，而其平均交易量为 936,485 股。该公司的市值为 5.1784 亿美元，市盈率为-2.64，贝塔值为 1.59。Cresco Labs 的 12 个月低点为$0.43，12 个月高点为$2.30。该公司的 50 日简单移动平均为$0.98，200 日简单移动平均为$1.06。公司的速动比率为 1.60，流动比率为 2.59，债务与股本比率为 1.72。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Separately, Zacks Research raised shares of Cresco Labs from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a report on Tuesday, March 31st. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company has an average rating of &#34;Buy&#34;.</p>
<div class="lb-trans"><p>另外，Zacks Research 在 3 月 31 日（星期二）的一份报告中将 Cresco Labs 的股票评级从 “强烈卖出” 上调至 “持有”。一位股票研究分析师给予该股票 “强烈买入” 评级，另一位则给予公司 “持有” 评级。根据 MarketBeat 的数据，该公司的平均评级为 “买入”。</p>
</div><p><strong>Check Out Our Latest Research Report on Cresco Labs</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Cresco Labs 的最新研究报告</strong></p>
</div><h2>Cresco Labs Company Profile</h2>
<div class="lb-trans"><h2>Cresco Labs 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Cresco Labs is a vertically integrated, multi-state cannabis operator in the United States. The company engages in the cultivation, manufacturing and distribution of a broad range of cannabis products, including flower, pre-rolled joints, concentrates, vaporizers, edibles and tinctures. Cresco Labs' operations span cultivation facilities, processing laboratories and a network of wholesale distribution centers that supply licensed dispensaries and retail outlets across key cannabis markets.</p>
<div class="lb-trans"><p>Cresco Labs 是一家在美国运营的垂直整合多州大麻公司。该公司从事各种大麻产品的种植、制造和分销，包括花朵、预卷烟、浓缩物、蒸汽器、食用产品和酊剂。Cresco Labs 的运营涵盖种植设施、加工实验室以及一个批发分销中心网络，向关键大麻市场的持牌药房和零售商供应产品。</p>
</div><p>The company's product portfolio is organized under several branded platforms, such as MÜV, Reserve and High Supply, each designed to address different segments of the adult-use and medical cannabis markets.</p>
<div class="lb-trans"><p>公司的产品组合分为多个品牌平台，如 MÜV、Reserve 和 High Supply，旨在满足成人使用和医疗大麻市场的不同细分市场。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Cresco Labs</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Cresco Labs 更好的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=OTCMKTS&amp;Symbol=CRLBF"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cresco Labs Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Cresco Labs 吗？</h2>
</div><p>Before you consider Cresco Labs, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Cresco Labs 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Cresco Labs 并不在名单上。</p>
</div><p>While Cresco Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Cresco Labs 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Cresco Labs (OTCMKTS:CRLBF) 公布财报，每股收益比预期低 0.01 美元